Cargando…

Additional value of volumetric and texture analysis on FDG PET assessment in paediatric Hodgkin lymphoma: an Italian multicentric study protocol

INTRODUCTION: Assessment of response to therapy in paediatric patients with Hodgkin lymphoma (HL) by 18F-fluorodeoxyglucose positron emission tomography/CT has become a powerful tool for the discrimination of responders from non-responders. The addition of volumetric and texture analyses can be rega...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopci, Egesta, Burnelli, Roberta, Elia, Caterina, Piccardo, Arnoldo, Castello, Angelo, Borsatti, Eugenio, Zucchetta, Pietro, Cistaro, Angelina, Mascarin, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009231/ https://www.ncbi.nlm.nih.gov/pubmed/33782017 http://dx.doi.org/10.1136/bmjopen-2020-041252

Ejemplares similares

Prospective Evaluation of Different Methods for Volumetric Analysis on [(18)F]FDG PET/CT in Pediatric Hodgkin Lymphoma
por: Lopci, Egesta, et al.
Publicado: (2022)

Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
por: De Re, Valli, et al.
Publicado: (2022)

The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma
por: Quartuccio, Natale, et al.
Publicado: (2013)

18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
por: Castello, Angelo, et al.
Publicado: (2020)

Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma
por: Primerano, Simona, et al.
Publicado: (2016)

Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [(18)F]FDG PET/CT in Metastatic Melanomas and Lung Cancer
por: Lopci, Egesta
Publicado: (2021)

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
por: De Re, Valli, et al.
Publicado: (2020)

Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0
por: Piccardo, Arnoldo, et al.
Publicado: (2022)

Proteomic Identification of Plasma Biomarkers in Children and Adolescents with Recurrent Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2018)

To Enhance or Not to Enhance? The Role of Contrast Medium (18)F-FDG PET/CT in Recurrent Ovarian Carcinomas
por: Massollo, Michela, et al.
Publicado: (2021)

Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2020)

Plasma Cell-Free DNA in Paediatric Lymphomas
por: Mussolin, Lara, et al.
Publicado: (2013)

Comparison of Metabolic and Morphological Response Criteria for Early Prediction of Response and Survival in NSCLC Patients Treated With Anti-PD-1/PD-L1
por: Castello, Angelo, et al.
Publicado: (2020)

Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint Inhibitors
por: Castello, Angelo, et al.
Publicado: (2021)

Meditating on Cancer Management at the Time of Immunotherapy
por: Lopci, Egesta
Publicado: (2022)

Soluble PD-L1 in NSCLC Patients Treated with Checkpoint Inhibitors and Its Correlation with Metabolic Parameters
por: Castello, Angelo, et al.
Publicado: (2020)

Comparison of MRI vs. [(18)F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives
por: Caracciolo, Matteo, et al.
Publicado: (2023)

FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
por: Aide, Nicolas, et al.
Publicado: (2018)

Imaging with non-FDG PET tracers: outlook for current clinical applications
por: Lopci, Egesta, et al.
Publicado: (2010)

Advances in Lung Cancer Imaging and Therapy
por: Lopci, Egesta, et al.
Publicado: (2021)

Editorial: Response assessment of radioligand therapies
por: Lopci, Egesta, et al.
Publicado: (2022)

Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence
por: Repetto, Ombretta, et al.
Publicado: (2021)

Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study
por: Spijkers, Suzanne, et al.
Publicado: (2020)

The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria
por: Castello, Angelo, et al.
Publicado: (2022)

The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors
por: Cistaro, Angelina, et al.
Publicado: (2021)

CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin’s and aggressive non-hodgkin’s lymphomas
por: Ganeshan, B., et al.
Publicado: (2016)

The role of 18F-FDG PET/CT in pediatric lymph-node acute lymphoblastic leukemia involvement
por: Cistaro, Angelina, et al.
Publicado: (2015)

Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors
por: Castello, Angelo, et al.
Publicado: (2020)

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma
por: De Re, Valli, et al.
Publicado: (2017)

Performance of (18)F-FDG PET/CT in Selecting Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytology for Surgery. A Systematic Review and a Meta-Analysis
por: Castellana, Marco, et al.
Publicado: (2019)

The dilemma of (18)F-FDG PET/CT thyroid incidentaloma: what we should expect from FNA. A systematic review and meta-analysis
por: Scappaticcio, Lorenzo, et al.
Publicado: (2021)

Radiomics analysis improves (18)FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules
por: Giovanella, Luca, et al.
Publicado: (2021)

Head-to-Head Comparison between (18)F-FES PET/CT and (18)F-FDG PET/CT in Oestrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis
por: Piccardo, Arnoldo, et al.
Publicado: (2022)

Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [(18)F]FDG PET/CT in Early Triple-Negative Breast Cancer
por: Bouron, Clément, et al.
Publicado: (2022)

Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study
por: Cistaro, Angelina, et al.
Publicado: (2021)

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
por: Daw, Stephen, et al.
Publicado: (2020)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Whole-body MRI versus an [(18)F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin’s lymphoma: a prospective multicentre study
por: Spijkers, Suzanne, et al.
Publicado: (2021)

[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023)

Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy
por: Linguanti, Flavia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7i6u0m12ko6m1nl6sbcv7dllbb